160 related articles for article (PubMed ID: 36414997)
41. The Drosophila homologue of the hereditary spastic paraplegia protein, spastin, severs and disassembles microtubules.
Roll-Mecak A; Vale RD
Curr Biol; 2005 Apr; 15(7):650-5. PubMed ID: 15823537
[TBL] [Abstract][Full Text] [Related]
42. The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function.
Trotta N; Orso G; Rossetto MG; Daga A; Broadie K
Curr Biol; 2004 Jul; 14(13):1135-47. PubMed ID: 15242610
[TBL] [Abstract][Full Text] [Related]
43. Structural basis of microtubule severing by the hereditary spastic paraplegia protein spastin.
Roll-Mecak A; Vale RD
Nature; 2008 Jan; 451(7176):363-7. PubMed ID: 18202664
[TBL] [Abstract][Full Text] [Related]
44. Truncating mutations of
Solowska JM; Rao AN; Baas PW
Mol Biol Cell; 2017 Jul; 28(13):1728-1737. PubMed ID: 28495799
[TBL] [Abstract][Full Text] [Related]
45. [Two novel mutations in gene SPG4 in patients with autosomal dominant spastic paraplegia].
Akhmetgaleyeva AF; Khidiyatova IM; Saifullina EV; Idrisova RF; Magzhanov RV; Khusnutdinova EK
Genetika; 2016 Jun; 52(6):691-6. PubMed ID: 29368828
[TBL] [Abstract][Full Text] [Related]
46. Modeling gain-of-function and loss-of-function components of SPAST-based hereditary spastic paraplegia using transgenic mice.
Piermarini E; Akarsu S; Connors T; Kneussel M; Lane MA; Morfini G; Karabay A; Baas PW; Qiang L
Hum Mol Genet; 2022 Jun; 31(11):1844-1859. PubMed ID: 34935948
[TBL] [Abstract][Full Text] [Related]
47. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.
Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM
Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751
[TBL] [Abstract][Full Text] [Related]
48. Syntaxin 13, a genetic modifier of mutant CHMP2B in frontotemporal dementia, is required for autophagosome maturation.
Lu Y; Zhang Z; Sun D; Sweeney ST; Gao FB
Mol Cell; 2013 Oct; 52(2):264-71. PubMed ID: 24095276
[TBL] [Abstract][Full Text] [Related]
49. Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia.
Zempel H; Mandelkow EM
Mol Neurodegener; 2015 Dec; 10():68. PubMed ID: 26691836
[TBL] [Abstract][Full Text] [Related]
50. Regulation of postsynaptic function by the dementia-related ESCRT-III subunit CHMP2B.
Chassefeyre R; Martínez-Hernández J; Bertaso F; Bouquier N; Blot B; Laporte M; Fraboulet S; Couté Y; Devoy A; Isaacs AM; Pernet-Gallay K; Sadoul R; Fagni L; Goldberg Y
J Neurosci; 2015 Feb; 35(7):3155-73. PubMed ID: 25698751
[TBL] [Abstract][Full Text] [Related]
51. Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners.
Sanderson CM; Connell JW; Edwards TL; Bright NA; Duley S; Thompson A; Luzio JP; Reid E
Hum Mol Genet; 2006 Jan; 15(2):307-18. PubMed ID: 16339213
[TBL] [Abstract][Full Text] [Related]
52. Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown.
Clayton EL; Milioto C; Muralidharan B; Norona FE; Edgar JR; Soriano A; Jafar-Nejad P; Rigo F; Collinge J; Isaacs AM
Brain; 2018 Dec; 141(12):3428-3442. PubMed ID: 30496365
[TBL] [Abstract][Full Text] [Related]
53. [Genetic testing in hereditary spastic paraplegia].
Hadzsiev K; Balikó L; Komlósi K; Lőcsei-Fekete A; Csábi G; Bene J; Kisfali P; Melegh B
Orv Hetil; 2015 Jan; 156(3):113-7. PubMed ID: 25577683
[TBL] [Abstract][Full Text] [Related]
54. Stop-gain mutations in UBAP1 cause pure autosomal-dominant spastic paraplegia.
Lin X; Su HZ; Dong EL; Lin XH; Zhao M; Yang C; Wang C; Wang J; Chen YJ; Yu H; Xu J; Ma LX; Xiong ZQ; Wang N; Chen WJ
Brain; 2019 Aug; 142(8):2238-2252. PubMed ID: 31203368
[TBL] [Abstract][Full Text] [Related]
55. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation.
McDermott CJ; Grierson AJ; Wood JD; Bingley M; Wharton SB; Bushby KM; Shaw PJ
Ann Neurol; 2003 Dec; 54(6):748-59. PubMed ID: 14681884
[TBL] [Abstract][Full Text] [Related]
56. Spastin recovery in hereditary spastic paraplegia by preventing neddylation-dependent degradation.
Sardina F; Pisciottani A; Ferrara M; Valente D; Casella M; Crescenzi M; Peschiaroli A; Casali C; Soddu S; Grierson AJ; Rinaldo C
Life Sci Alliance; 2020 Dec; 3(12):. PubMed ID: 33106322
[TBL] [Abstract][Full Text] [Related]
57. Spastin, the most commonly mutated protein in hereditary spastic paraplegia interacts with Reticulon 1 an endoplasmic reticulum protein.
Mannan AU; Boehm J; Sauter SM; Rauber A; Byrne PC; Neesen J; Engel W
Neurogenetics; 2006 May; 7(2):93-103. PubMed ID: 16602018
[TBL] [Abstract][Full Text] [Related]
58. Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.
Roos P; Johannsen P; Lindquist SG; Brown JM; Waldemar G; Duno M; Nielsen TT; Budtz-Jørgensen E; Gydesen S; Holm IE; Collinge J; Isaacs AM; ; Nielsen JE
Acta Neurol Scand; 2022 May; 145(5):529-540. PubMed ID: 34997757
[TBL] [Abstract][Full Text] [Related]
59. Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia.
McCorquodale DS; Ozomaro U; Huang J; Montenegro G; Kushman A; Citrigno L; Price J; Speziani F; Pericak-Vance MA; Züchner S
Clin Genet; 2011 Jun; 79(6):523-30. PubMed ID: 20718791
[TBL] [Abstract][Full Text] [Related]
60. The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling.
Tsang HT; Edwards TL; Wang X; Connell JW; Davies RJ; Durrington HJ; O'Kane CJ; Luzio JP; Reid E
Hum Mol Genet; 2009 Oct; 18(20):3805-21. PubMed ID: 19620182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
